BioMarin to Participate in the BofA Securities 2022 Healthcare Conference, Thursday, May 12 at 8:40amPT/11:40amET

Rhea-AI Summary

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced that CEO Jean-Jacques Bienaimé will present at the BofA Securities Healthcare Conference on May 12, 2022, at 8:40 am PT/11:40 am ET in Las Vegas. Interested individuals can access the live webcast on the BioMarin website. A replay will be available for 90 days post-event. BioMarin specializes in developing therapies for serious rare diseases, with a portfolio of seven commercial products and various clinical candidates.

News Market Reaction – BMRN

+1.35%

+1.35% Session move

In the trading session that priced this news, BMRN gained 1.35%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN RAFAEL, Calif., May 4, 2022 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will present at the BofA Securities Healthcare Conference on May 12 at 8:40am PT/11:40am ET in Las Vegas. To access the live webcast, please visit the BioMarin website, https://investors.biomarin.com/.

BioMarin to Present at the 2022 BofA Securities Healthcare Conference on May 12, 2022

A replay of the webcast will be available for 90 days.

About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare diseases and medical conditions. The Company selects product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a significant benefit over existing products. The Company's portfolio consists of seven commercial products and multiple clinical and preclinical product candidates for the treatment of various diseases.

For additional information, please visit www.biomarin.com.

Contacts:
Investors	Media
Traci McCarty	Debra Charlesworth
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(415) 455-7451

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-the-bofa-securities-2022-healthcare-conference-thursday-may-12-at-840ampt1140amet-301539505.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When will BioMarin's CEO present at the BofA Securities Healthcare Conference?

Jean-Jacques Bienaimé will present on May 12, 2022, at 8:40 am PT/11:40 am ET.

Where can I watch BioMarin's presentation at the healthcare conference?

You can access the live webcast on the BioMarin website.

What is BioMarin Pharmaceutical known for?

BioMarin develops innovative therapies for serious and life-threatening rare diseases.

Is there a replay available for BioMarin's conference presentation?

Yes, a replay of the webcast will be available for 90 days.

What is the stock symbol for BioMarin Pharmaceutical?

The stock symbol for BioMarin is BMRN.